ARCHIVES

HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought

This article is from The Cancer Letter archive.

Vol. 10 No. 30 | July 27, 1984

Download PDF Visit The Full Archive

Related Articles

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014

Business & Regulatory Report March edition (8 pages) included.

March 19, 2004

An Appreciation: Janet Rowley, “Translational Research Pioneer”

January 3, 2014

Antman, Clanton begin work at NCI.

December 5, 2003

NCI budget: a “Yes” to one thing means a “No” to something else, director says.

February 27, 2004

Breast Cancer Report To The Profession Suddenly Is a Report To The Nation; Treatment Progress Noted

October 4, 1974